DISCUSSION POINTS
1. Prandoni et al 1 performed a systematic evaluation for pulmonary embolism (PE) among admitted patients with syncope at 11 Italian hospitals. A. What was the study's primary result? Does the study result reflect your clinical experience? B. Describe the admission criteria for syncope in these hospitals. Are these admission practices similar to those in your practice setting? C. Discuss the apparent morbidity level of the patients included in the study cohort. How does the baseline disease burden of the patients in this study compare with that of syncope patients in your emergency department ( The primary outcome was prevalence of PE in patients admitted for syncope. The authors concluded that 1 in 6 admitted patients with syncope had PE as the cause. Although every hospital and practice setting is unique, our experience in urban private and public hospitals in the United States suggests that PE as the cause of syncope is substantially less common than suggested by this study.
Q1.b Describe the admission criteria for syncope in these hospitals. Are these admission practices similar to those in your practice setting?
Admission criteria in this study included syncope plus trauma related to falls, severe coexisting conditions, failure to identify an explanation, or high probability of cardiac cause. Although there is variation in admission criteria for syncope among different providers and practice settings, the stated criteria are not dissimilar to those in our own practice.
Q1.c Discuss the apparent morbidity level of the patients included in the study cohort. How does the baseline disease burden of the patients in this study compare with syncope patients in your ED?
To understand the external validity of this study, we need a clear picture of the baseline morbidity of the patients. Unfortunately, the article does not provide a great deal of detail in regard to baseline morbidity. We do know that the mean age of patients in the study was 76 years and obesity rate was low. The authors do disclose the rates of recent trauma, surgery, active cancer, and infectious disease. Patient age and cancer prevalence are substantially higher than in our syncope population. Comorbidities alone might contribute to the high rate of PE in the study population. Unfortunately, we are provided only with ecologic data and little sense of each patient's condition and how that related to PE risk.
Q1.d How might study results differ from those of a study conducted in hospitals like yours?
In emergency medicine, we are much less concerned with the prevalence of PE in admitted syncope patients. What is more relevant is determining the appropriate threshold to commence PE evaluations in unselected groups of patients presenting to the ED with syncope. Although there is a small amount of data on the undifferentiated patient presenting to the ED with syncope, they are sparse and largely outdated. [2] [3] [4] Inpatients, on the other hand, appear to have a high prevalence of PE in syncope. 5 We would be surprised if the PE rate were anywhere near as high as reported in this study among an undifferentiated group of syncope patients in a typical United States ED.
ANSWER 2
Q2.a The authors used the Evaluation of Guidelines in Syncope Study Score to determine the probability of cardiac syncope. What elements does that score use?
The Evaluation of Guidelines in Syncope Study Score uses the following elements: abnormal ECG result or heart disease, palpitations before syncope, syncope during effort or in supine position, absence of autonomic prodromes, and presence of classic syncope risk factors such as warm crowded places, prolonged standing, pain, fear, or emotion. 6 The higher the score, the higher the probability of cardiac syncope.
Q2.b What objective tests did all patients who presented with syncope undergo? Is this different from the evaluation you typically order for a patient with syncope?
All patients with syncope underwent chest radiography, ECG, arterial blood gas testing, and "routine blood testing" that included a D-dimer assay. If indicated, patients underwent carotid sinus massage, tilt testing, echocardiography, and 24-hour electrocardiography. In the ED, many of the tests described in this article are obviously not performed. In our experience, there is great variation in ED syncope evaluations. Many clinicians rely heavily on history and physical, whereas others adhere to the San Francisco Syncope Rule. 7, 8 Some physicians perform a battery of investigations regardless of perceived risk.
ANSWER 3
Q3.a What risk-stratification scores exist for PE? Which scores were used in Prandoni et al? Which ones do you use clinically?
The Wells criteria, 9 pulmonary embolism rule-out criteria rule, 10 and Geneva score 11 are 3 commonly used risk-stratification tools for PE in the ED. This is not explicitly stated, but syncope patients who were admitted to the hospital and entered into the study (22% of all syncope patients) appeared to have a fairly standard evaluation of Wells stratification, D-dimer, and ventilation perfusion or computed tomography (CT) pulmonary angiogram imaging if indicated.
The authors' approach to the evaluation of PE is not broadly agreed on. The American College of Emergency Physicians' clinical policy on management of suspected PE states that either objective criteria or gestalt can be used to risk-stratify patients because there is insufficient evidence to support the preferential use of one over the other.
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Q3.c Were the PEs diagnosed in this study clinically relevant? Do you think the PEs diagnosed in the study explain the presentation of syncope?
The clinical importance of the diagnosed PEs in this study is unclear. Indeed, the clinical significance of many diagnosed PEs is unclear. 13 The implication of this study is that the PEs diagnosed in patients with syncope were actually the cause of their syncope. The study provides no direct evidence for this conclusion, and in sicker patients with other clot-promoting disease processes, these findings may well be incidental.
ANSWER 4
Q4. The study concludes that 17.3% of patients hospitalized for syncope have a PE.
Q4.a Of all patients who visited the ED for syncope, what percent of them received a definitive diagnosis of PE?
Of the 2,584 patients who visited the ED for syncope, 97 had a confirmed PE. That equates to approximately 4% of the patients presenting to the study hospitals for syncope.
Q4.b How did the study authors account for patients who died or were lost to follow-up?
They report only one death in the study group and confirmed PE on autopsy, but the accuracy of this practice has been questioned.
14 There were no patients lost to follow-up.
Q4.c What was the mean age of patients in the study population? How does this change the way you interpret the data?
The mean age of patients enrolled was 76 years. Increasing age is associated with elevated disease burden and PE risk. Clinicians working with generally younger patient populations can reasonably expect the PE rate to be substantially lower than in this study.
Q4.d How does this study affect your decision to aggressively evaluate syncope patients for PE in the ED who do not otherwise appear to have a PE? What would be the downstream effects if more of these patients were to undergo workup for PE?
After reading this article, some providers may consider additional, aggressive diagnostic tests to rule out PE in patients who present with syncope. Increased diagnostic testing for PE will inevitably result in increases in CT pulmonary angiogram use, cost, length of stay, and radiation exposure. Should additional PEs be detected, it remains wholly unclear whether these patients will benefit from their detection and treatment. 13 
ANSWER 5
Q5. One's interpretation of this study is highly dependent on understanding exactly who was included in the study.
Q5.a What exactly do you know about these patients (and the patients who were excluded)? What do you not know that you would like to know?
Patients included in the study were aged 18 years or older, with a first-ever episode of syncope. Patients were admitted if there was trauma related to the fall, severe coexisting conditions, failure to identify an explanation for syncope, or a high probability of cardiac syncope. Among the excluded patients were those who were pregnant, had previous episodes of syncope, or were receiving anticoagulation. One thousand eight hundred sixty-seven patients with syncope were discharged directly from the ED because the cause of their syncope was considered obvious or, in 81 cases, they refused admission. We do not know which of the discharged patients may have had a PE identified if further evaluation had been pursued.
A more detailed explanation of the differences between the patients entered in the study and those admitted for evaluation would be helpful in determining external validity.
Q5.b This study design falls under the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline. 15 What does STROBE say about how the study cohort should be described? Did the authors meet the STROBE requirement? If not, how so? If yes, is STROBE adequate to ensure reporting that is sufficient to allow us to determine the external validity of the study?
According to the STROBE guidelines, the study cohort participants should include a description of the eligibility criteria, include the sources and methods of selection of participants, and describe methods of follow-up. There should be an explanation of how loss to follow-up was addressed. This study does follow the STROBE guidelines, but there is a level of detail that is missing. In general, it is extremely helpful to provide a very clear description of the types of patients enrolled in the study so that one can compare the study cohort to one's own patient population and determine whether study findings are likely to be relevant. Authorship: All authors attest to meeting the four ICMJE.org authorship criteria: (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
